2AB:FRA
Barinthus Biotherapeutics PLC - ADR
€0.58
arrow_downward
-3.31%(-0.020) 1D
Sep 4, 10:00:00 PM GMT+2 · EUR
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 2AB...
Open
€0.58
High
€0.58
Low
€0.58
Mkt. cap
30.98M
Avg. vol.
40.00
Volume
0.00
52-wk high
€1.30
52-wk low
€0.45
No. of employees
14
Open
€0.58
High
€0.58
Low
€0.58
Mkt. cap
30.98M
Avg. vol.
40.00
Volume
0.00
52-wk high
€1.30
52-wk low
€0.45
No. of employees
14
Profile
Barinthus Biotherapeutics plc is a biotechnology company developing immunotherapies for infectious diseases, cancer and autoimmune diseases such as hepatitis B, HPV and prostate cancer. Formerly known as Vaccitech plc, in November 2023 the company announced that it had renamed itself to Barinthus Biotherapeutics plc. As of 2024, the company employs more than 100 people. Wikipedia
About Barinthus Biotherapeutics PLC - ADR